Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.13 is 59% below its 5-year average of 19.82, near the low end of its 5-year range (3.18–51.16).
As of the fiscal period ended Tuesday, June 30, 2026. 31.86% below its 12-month average of 11.93.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.13.
CURRENT RATIO
8.13
CURRENT RATIO AVG TTM
11.93
CURRENT RATIO AVG 3Y
15.85
CURRENT RATIO AVG 5Y
19.82
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-31.86%
CURRENT VS 3Y AVG
-48.70%
CURRENT VS 5Y AVG
-58.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 566 covered companies
CURRENT VS SECTOR MEDIAN
+143.07%
vs the sector median at left
Atea Pharmaceuticals, Inc.
Market Cap
$412.14M
Current Ratio
8.13
TTM Avg
11.93
3Y Avg
15.85
5Y Avg
19.82
Market Cap
$411.45M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$408.54M
Current Ratio
10.71
TTM Avg
7.83
3Y Avg
8.94
5Y Avg
8.94
Market Cap
$392.24M
Current Ratio
5.88
TTM Avg
5.65
3Y Avg
4.80
5Y Avg
5.41
Market Cap
$434.84M
Current Ratio
7.35
TTM Avg
8.39
3Y Avg
5.06
5Y Avg
6.73
Market Cap
$389.14M
Current Ratio
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
Market Cap
$441.36M
Current Ratio
13.99
TTM Avg
3.82
3Y Avg
4.25
5Y Avg
5.96
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $412.14M | 8.13 | 11.93 | 15.85 | 19.82 |
| Carlsmed, Inc. (CARL)vs › | $412.76M | 8.84 | 7.23 | 5.35 | 5.35 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $411.45M | 9.89 | 6.34 | 6.34 | 6.34 |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | 10.71 | 7.83 | 8.94 | 8.94 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $392.24M | 5.88 | 5.65 | 4.80 | 5.41 |
| Editas Medicine, Inc. (EDIT)vs › | $432.00M | 3.19 | 3.65 | 4.66 | 6.11 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $434.84M | 7.35 | 8.39 | 5.06 | 6.73 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $389.14M | 16.52 | 13.61 | 8.86 | 8.86 |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.36M | 13.99 | 3.82 | 4.25 | 5.96 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $378.75M | 9.06 | 8.18 | 5.96 | 5.74 |
Current Ratio
8.13
Quick Ratio
8.13
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.13 |
| 2026-03-31 | 7.89 |
| 2025-12-31 | 7.82 |
| 2025-09-30 | 16.66 |
| 2025-06-30 | 19.17 |
| 2025-03-31 | 19.94 |
| 2024-12-31 | 24.85 |
| 2024-09-30 | 19.33 |
| 2024-06-30 | 19.02 |
| 2024-03-31 | 13.28 |
| 2023-12-31 | 18.24 |
| 2023-09-30 | 31.93 |
| 2023-06-30 | 38.42 |
| 2023-03-31 | 51.16 |
| 2022-12-31 | 35.77 |
| 2022-09-30 | 43.62 |
| 2022-06-30 | 27.46 |
| 2022-03-31 | 24.93 |
| 2021-12-31 | 13.58 |
| 2021-09-30 | 3.22 |
| 2021-06-30 | 3.18 |
| 2021-03-31 | 3.30 |
| 2020-12-31 | 2.73 |
| 2020-09-30 | 10.02 |
| 2020-06-30 | 16.78 |
| 2020-03-31 | 9.13 |
| 2019-12-31 | 9.00 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
